The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer's disease
Abstract
Introduction: Profiling the spatial‐temporal expression pattern and characterizing the regulatory networks of brain tissues are vital for understanding the pathophysiology of Alzheimer's disease (AD). Methods: We performed a systematic integrated analysis of expression profiles of AD‐affected brain tissues (684 AD and 562 controls). A network‐based convergent functional genomic approach was used to prioritize possible regulator genes during AD development, followed by functional characterization. Results: We generated a complete list of differentially expressed genes and hub genes of the transcriptomic network in AD brain and constructed a Web server (www.alzdata.org) for public access. Seventeen hub genes active at the early stages, especially YAP1, were recognized as upstream regulators of the AD network. Cellular assays proved that early alteration of YAP1 could promote AD by influencing the whole transcriptional network. Discussion: Early expression disturbance of hub genes is an important feature of AD development, and interfering with this process may reverse the disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903 · cited 2×
“Identification of the hub genes, which are essential for the integrity of the functional module [60], offers a possibility to explore the disrupted regulatory pattern in AD brain.”
BackgroundA General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684 · cited 3×
“S9) analysis were performed using DESeq2 [41].”
MethodInfluential2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · cited 9×
“Expression correlation (r) of the targe performed for the Ab line AD mice in Mouseac (marked as Ab) [50] and the tau alterations in hippocampus of 2-month-old AD mice (in an order of HO-TASTPM gous APP/PSEN1 double mutant mice, TAS10: humanmutant APPmice, TAU:mu changes of the target gene in AD patients in the merged…”
BackgroundMethodInfluentialNeuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 4×
“Intriguingly, DEGs related to the Hippo signaling pathway were enriched in EC (the first brain region affected by AD [1]), which has not been reported in individual expression studies.”
BackgroundInfluentialThe Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · cited 1×
“It should be mentioned that the neuronal expressed genes might appear to be lower in AD samples, as AD-affected brain regions had fewer neurons and greater numbers of microglia and astrocyte among AD subjects compared with controls [67].”
ResultDefining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R
Langfelder, P., Zhang, B., & Horvath, S. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm563 · Cited by 1,892
The Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · cited 3×
“combined massive microarray (376 AD patients and 173 controls) and eQTL data and identified a hub gene TYROBP as the key causal regulator of the microglia module in AD brain [24].”
BackgroundMethodA survey of human brain transcriptome diversity at the single cell level
Darmanis, S., Sloan, S. A., Zhang, Y., Enge, M., Caneda, C., Shuer, L. M., Hayden Gephart, M. G., Barres, B. A., & Quake, S. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507125112 · Cited by 1,401
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357
Fast R Functions for Robust Correlations and Hierarchical Clustering
Langfelder, P., & Horvath, S. (2012) · Journal of Statistical Software · doi:10.18637/jss.v046.i11 · Cited by 1,279
The emerging roles of YAP and TAZ in cancer
Moroishi, T., Hansen, C. G., & Guan, K.-L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3876 · Cited by 1,145
Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., & Landfield, P. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308512100 · Cited by 1,025
Is My Network Module Preserved and Reproducible?
Langfelder, P., Luo, R., Oldham, M. C., & Horvath, S. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001057 · Cited by 1,012 · cited 22×
“Abbreviations: AD, Alzheimer’s disease; CFG, convergent e; DEG, differentially expressed gene; eQTL, the total number of risk SNPs the target gene (Braincloud [47], P, .001); GWAS, the total number of risk core genes (APP, PSEN1, PSEN2, MAPT, and APOE) that had a significant P , .05; **P , .01; ***P , .001. have taken…”
BackgroundMethodInfluentialSelf-citationGeometric Interpretation of Gene Coexpression Network Analysis
Horvath, S., & Dong, J. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000117 · Cited by 851
REST and stress resistance in ageing and Alzheimer’s disease
Lu, T., Aron, L., Zullo, J., Pan, Y., Kim, H., Chen, Y., Yang, T.-H., Kim, H.-M., Drake, D., Liu, X. S., et al. (2014) · Nature · doi:10.1038/nature13163 · Cited by 772
Al-Atrache, Z., Cader, A., & Appelt, D. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.894 · Cited by 765
The Genetics of Alzheimer's Disease
Bertram, L., & Tanzi, R. E. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00008-4 · Cited by 760
The genetics of Alzheimer disease
Tanzi, R. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006296 · Cited by 727
Temporal dynamics and genetic control of transcription in the human prefrontal cortex
Colantuoni, C., Lipska, B. K., Ye, T., Hyde, T. M., Tao, R., Leek, J. T., Colantuoni, E. A., Elkahloun, A. G., Herman, M. M., Weinberger, D. R., et al. (2011) · Nature · doi:10.1038/nature10524 · Cited by 685
GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop
Montojo, J., Zuberi, K., Rodriguez, H., Kazi, F., Wright, G., Donaldson, S. L., Morris, Q., & Bader, G. D. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq562 · Cited by 631
Gene expression changes in the course of normal brain aging are sexually dimorphic
Berchtold, N. C., Cribbs, D. H., Coleman, P. D., Rogers, J., Head, E., Kim, R., Beach, T., Miller, C., Troncoso, J., Trojanowski, J. Q., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806883105 · Cited by 626
Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585 · cited 4×
“Consistent with previous studies [7,9,10,28], the expression pattern of well-known AD-risk genes, such as APP, PSEN1, and PSEN2, across EC, HP, TC, and FC was only slightly altered or unchanged in AD patients.”
BackgroundResultInfluentialCellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
Mo, J.-S., Meng, Z., Kim, Y. C., Park, H. W., Hansen, C. G., Kim, S., Lim, D.-S., & Guan, K.-L. (2015) · Nature Cell Biology · doi:10.1038/ncb3111 · Cited by 557
Chen, C., Grennan, K., Badner, J., Zhang, D., Gershon, E., Jin, L., & Liu, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017238 · Cited by 542
Self-citationCribbs, D. H., Berchtold, N. C., Perreau, V., Coleman, P. D., Rogers, J., Tenner, A. J., & Cotman, C. W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-179 · Cited by 499 · cited 3×
“By January 2016, a total of 20 expression datasets were obtained: GSE12685 [1], GSE48350 [2], GSE66333 [3], GSE53890 [4], GSE36980 [5], GSE13214 [6], GSE15222 [7], GSE5281 [8, 9], GSE44770 [10], GSE33000 [11], GSE9770 [12], GSE37264 (exon level) [13], GSE37263 (gene level) [14], GSE29652 [15], GSE28146 [16], GSE1297 […”
BackgroundYAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers
Stein, C., Bardet, A. F., Roma, G., Bergling, S., Clay, I., Ruchti, A., Agarinis, C., Schmelzle, T., Bouwmeester, T., Schübeler, D., et al. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005465 · Cited by 414 · cited 1×
“Although our finding indicates a protective role of increased YAP1 level in AD, elevated YAP1 activity has been found in several types of human cancers [81,83,88].”
BackgroundA Systems Level Analysis of Transcriptional Changes in Alzheimer's Disease and Normal Aging
Miller, J. A., Oldham, M. C., & Geschwind, D. H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4098-07.2008 · Cited by 385
Fernandez-L, A., Northcott, P. A., Dalton, J., Fraga, C., Ellison, D., Angers, S., Taylor, M. D., & Kenney, A. M. (2009) · Genes & Development · doi:10.1101/gad.1824509 · Cited by 377
Liang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Walker, D. G., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., et al. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00208.2006 · Cited by 342
Luo, J., Schumacher, M., Scherer, A., Sanoudou, D., Megherbi, D., Davison, T., Shi, T., Tong, W., Shi, L., Hong, H., et al. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.57 · Cited by 331
Accelerated neurodegeneration through chaperone-mediated oligomerization of tau
Blair, L. J., Nordhues, B. A., Hill, S. E., Scaglione, K. M., O’Leary, J. C., Fontaine, S. N., Breydo, L., Zhang, B., Li, P., Wang, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69003 · Cited by 322 · cited 3×
“By January 2016, a total of 20 expression datasets were obtained: GSE12685 [1], GSE48350 [2], GSE66333 [3], GSE53890 [4], GSE36980 [5], GSE13214 [6], GSE15222 [7], GSE5281 [8, 9], GSE44770 [10], GSE33000 [11], GSE9770 [12], GSE37264 (exon level) [13], GSE37263 (gene level) [14], GSE29652 [15], GSE28146 [16], GSE1297 […”
BackgroundAltered Expression of Diabetes-Related Genes in Alzheimer's Disease Brains: The Hisayama Study
Hokama, M., Oka, S., Leon, J., Ninomiya, T., Honda, H., Sasaki, K., Iwaki, T., Ohara, T., Sasaki, T., LaFerla, F. M., et al. (2014) · Cerebral Cortex · doi:10.1093/cercor/bht101 · Cited by 322
Genetic Control of Human Brain Transcript Expression in Alzheimer Disease
Webster, J. A., Gibbs, J. R., Clarke, J., Ray, M., Zhang, W., Holmans, P., Rohrer, K., Zhao, A., Marlowe, L., Kaleem, M., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.011 · Cited by 304 · cited 4×
“Consistent with previous studies [7,9,10,28], the expression pattern of well-known AD-risk genes, such as APP, PSEN1, and PSEN2, across EC, HP, TC, and FC was only slightly altered or unchanged in AD patients.”
ResultInfluentialBerchtold, N. C., Coleman, P. D., Cribbs, D. H., Rogers, J., Gillen, D. L., & Cotman, C. W. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.024 · Cited by 298
Matarin, M., Salih, D. A., Yasvoina, M., Cummings, D. M., Guelfi, S., Liu, W., Nahaboo Solim, M. A., Moens, T. G., Paublete, R. M., Ali, S. S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.041 · Cited by 290
Genes and pathways underlying regional and cell type changes in Alzheimer’s disease
Miller, J. A., Woltjer, R. L., Goodenbour, J. M., Horvath, S., & Geschwind, D. H. (2013) · Genome Medicine · doi:10.1186/gm452 · Cited by 275
Taminau, J., Meganck, S., Lazar, C., Steenhoff, D., Coletta, A., Molter, C., Duque, R., Schaetzen, V. D., Weiss Solís, D. Y., Bersini, H., et al. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-335 · Cited by 231
Bossers, K., Wirz, K. T. S., Meerhoff, G. F., Essing, A. H. W., van Dongen, J. W., Houba, P., Kruse, C. G., Verhaagen, J., & Swaab, D. F. (2010) · Brain · doi:10.1093/brain/awq258 · Cited by 230
Disease implications of the Hippo/YAP pathway
Plouffe, S. W., Hong, A. W., & Guan, K.-L. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.003 · Cited by 229
Gene expression profiling in human neurodegenerative disease
Cooper-Knock, J., Kirby, J., Ferraiuolo, L., Heath, P. R., Rattray, M., & Shaw, P. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.156 · Cited by 223
Astarita, G., Jung, K.-M., Berchtold, N. C., Nguyen, V. Q., Gillen, D. L., Head, E., Cotman, C. W., & Piomelli, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012538 · Cited by 218 · cited 3×
“9 [12] Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Ramsey K, et al.”
BackgroundTEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors
Cebola, I., Rodríguez-Seguí, S. A., Cho, C. H.-H., Bessa, J., Rovira, M., Luengo, M., Chhatriwala, M., Berry, A., Ponsa-Cobas, J., Maestro, M. A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3160 · Cited by 215
Blalock, E. M., Buechel, H. M., Popovic, J., Geddes, J. W., & Landfield, P. W. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.06.007 · Cited by 211
Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases
Narayanan, M., Huynh, J. L., Wang, K., Yang, X., Yoo, S., McElwee, J., Zhang, B., Zhang, C., Lamb, J. R., Xie, T., et al. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145304 · Cited by 208
NICULESCU, A. B., SEGAL, D. S., KUCZENSKI, R., BARRETT, T., HAUGER, R. L., & KELSOE, J. R. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.4.1.83 · Cited by 206
Simpson, J. E., Ince, P. G., Shaw, P. J., Heath, P. R., Raman, R., Garwood, C. J., Gelsthorpe, C., Baxter, L., Forster, G., Matthews, F. E., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.013 · Cited by 192
Gene expression correlates of neurofibrillary tangles in Alzheimer's disease
Dunckley, T., Beach, T. G., Ramsey, K. E., Grover, A., Mastroeni, D., Walker, D. G., LaFleur, B. J., Coon, K. D., Brown, K. M., Caselli, R., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.013 · Cited by 177 · cited 3×
“[6] Dunckley T, Beach TG, Ramsey KE, Grover A, Mastroeni D, Walker DG, et al.”
BackgroundToll-Like Receptors in Alzheimer's Disease
Landreth, G. E., & Reed-Geaghan, E. G. (2009) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-00549-7_8 · Cited by 176
Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer
Yimlamai, D., Fowl, B. H., & Camargo, F. D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.008 · Cited by 174
Musah, S., Wrighton, P. J., Zaltsman, Y., Zhong, X., Zorn, S., Parlato, M. B., Hsiao, C., Palecek, S. P., Chang, Q., Murphy, W. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415330111 · Cited by 169
Berson, A., Barbash, S., Shaltiel, G., Goll, Y., Hanin, G., Greenberg, D. S., Ketzef, M., Becker, A. J., Friedman, A., & Soreq, H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100995 · Cited by 167
Durrenberger, P. F., Fernando, F. S., Kashefi, S. N., Bonnert, T. P., Seilhean, D., Nait‐Oumesmar, B., Schmitt, A., Gebicke‐Haerter, P. J., Falkai, P., Grünblatt, E., et al. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1293-0 · Cited by 150
Oocyte-expressed yes-associated protein is a key activator of the early zygotic genome in mouse
Yu, C. Y., Ji, S., Dang, Y.-J., Sha, Q., Yuan, Y.-F., Zhou, J.-J., Yan, L.-Y., Qiao, J., Tang, F., & Fan, H. (2016) · Cell Research · doi:10.1038/cr.2016.20 · Cited by 148
Yap and Taz regulate retinal pigment epithelial cell fate
Miesfeld, J. B., Gestri, G., Clark, B. S., Flinn, M. A., Poole, R. J., Bader, J. R., Besharse, J. C., Wilson, S. W., & Link, B. A. (2015) · Development · doi:10.1242/dev.119008 · Cited by 143 · cited 1×
“Note that YAP1 and TAZ are major downstream effectors of the Hippo pathway that regulates key processes related to cell growth, tissue homeostasis, organ size, and regeneration [81–83], especially in ocular development [84,85] and liver regeneration [86].”
Modeling of epigenome dynamics identifies transcription factors that mediate Polycomb targetingPreprint
Arnold, P., Schöler, A., Pachkov, M. V., Balwierz, P. J., Jørgensen, H. F., Stadler, M. B., van Nimwegen, E., & Schübeler, D. (2012) · Genome Research · doi:10.1101/gr.142661.112 · Cited by 139
Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease
Tan, M. G., Chua, W. T., Esiri, M. M., Smith, A. D., Vinters, H. V., & Lai, M. K. P. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22290 · Cited by 127
YAP stabilizes SMAD1 and promotes BMP2-induced neocortical astrocytic differentiation
Huang, Z., Hu, J., Pan, J., Wang, Y., Hu, G., Zhou, J., Mei, L., & Xiong, W. (2016) · Development · doi:10.1242/dev.130658 · Cited by 127
Williams, C., Mehrian Shai, R., Wu, Y., Hsu, Y.-H., Sitzer, T., Spann, B., McCleary, C., Mo, Y., & Miller, C. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004936 · Cited by 116 · cited 1×
“After manual inspection and filtration, there were four data sets retained for EC (GSE26927 [18,29], GSE48350 [8], GSE26972 [16], GSE5281 [7,9]); five data sets for HP (GSE28146 [14], GSE48350 [8], GSE5281 [7,9], GSE29378 [23], GSE36980 [25]); five data sets for TC (GSE37263 [13], GSE29652 [15], GSE36980 [25], GSE1522…”
Self-citationAntonell, A., Lladó, A., Altirriba, J., Botta‐Orfila, T., Balasa, M., Fernández, M., Ferrer, I., Sánchez‐Valle, R., & Molinuevo, J. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.026 · Cited by 113
YAP Is a Critical Inducer of SOCS3, Preventing Reactive Astrogliosis
Huang, Z., Wang, Y., Hu, G., Zhou, J., Mei, L., & Xiong, W. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv292 · Cited by 111
Puthiyedth, N., Riveros, C., Berretta, R. E., & Moscato, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152342 · Cited by 108
Durrenberger, P. F., Fernando, F. S., Magliozzi, R., Kashefi, S. N., Bonnert, T. P., Ferrer, I., Seilhean, D., Nait-Oumesmar, B., Schmitt, A., Gebicke-Haerter, P. J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1027-z · Cited by 107
Regulation of transmitter release by Ca2+ and synaptotagmin: insights from a large CNS synapse
Kochubey, O., Lou, X., & Schneggenburger, R. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.02.006 · Cited by 100
The human gene connectome as a map of short cuts for morbid allele discovery
Itan, Y., Zhang, S., Vogt, G., Abhyankar, A., Casadio, M., Nitschké, P., Fried, D., Quintana‐Murci, L., Abel, L., & Casanova, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218167110 · Cited by 97
Concerted Perturbation Observed in a Hub Network in Alzheimer’s Disease
Liang, D., Han, G., Feng, X., Sun, J., Duan, Y., & Lei, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040498 · Cited by 93
Sárvári, M., Hrabovszky, E., Kalló, I., Solymosi, N., Likó, I., Berchtold, N. C., Cotman, C. W., & Liposits, Z. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-264 · Cited by 88
Liang, W. S., Dunckley, T. L., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K. M., Caselli, R. J., Kukull, W. A., McKeel, D. W., Morris, J. C., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.013 · Cited by 86
Kim, J. Y., Park, R., Lee, J. H. J., Shin, J., Nickas, J. M., Kim, S., & Cho, S. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.09.001 · Cited by 83
CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer’s Disease
Initiative, A. D. N., Zhang, D., Li, J., Wu, H., Cui, Y. J., Bi, R., Zhou, H., Wang, H.-Z., Zhang, C., Wang, D., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.232 · Cited by 77
Self-citationTaminau, J., Lazar, C., Meganck, S., & Nowé, A. (2014) · ISRN Bioinformatics · doi:10.1155/2014/345106 · Cited by 77
Coassembly of REST and its cofactors at sites of gene repression in embryonic stem cells
Yu, H.-B., Johnson, R., Kunarso, G., & Stanton, L. W. (2011) · Genome Research · doi:10.1101/gr.114488.110 · Cited by 72
Niculescu, A. B., & Le-Niculescu, H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.107 · Cited by 55
HGCS: an online tool for prioritizing disease-causing gene variants by biological distance
Itan, Y., Mazel, M., Mazel, B., Abhyankar, A., Nitschké, P., Quintana‐Murci, L., Boisson‐Dupuis, S., Boisson, B., Abel, L., Zhang, S., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-256 · Cited by 51
Simpson, J. E., Ince, P. G., Minett, T., Matthews, F. E., Heath, P. R., Shaw, P. J., Goodall, G., Garwood, C. J., Ratcliffe, L. E., Brayne, C., et al. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12252 · Cited by 49
Novel Mediators of Amyloid Precursor Protein Signaling
Swistowski, A., Zhang, Q., Orcholski, M. E., Crippen, D., Vitelli, C., Kurakin, A. V., & Bredesen, D. E. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4351-09.2009 · Cited by 41
Silva, A. R. T., Grinberg, L. T., Farfel, J. M., Diniz, B. S., Lima, L. A., Silva, P. J. S., Ferretti, R. E. L., Rocha, R. M., Filho, W. J., Carraro, D. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048751 · Cited by 40 · cited 5×
“EC GSE26927 [19, 20] 11 4 15 GPL6255 17189 7.”
BackgroundInfluentialMukherjee, S., Russell, J. C., Carr, D. T., Burgess, J. D., Allen, M., Serie, D. J., Boehme, K. L., Kauwe, J. S. K., Naj, A. C., Fardo, D. W., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.016 · Cited by 39 · cited 2×
“integrated massive PPI with genetic association data and indicated novel AD-risk genes [71], and this acts as a good example of this method.”
BackgroundMethodXiang, Q., Bi, R., Xu, M., Zhang, D., Tan, L., Zhang, C., Fang, Y., & Yao, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0065-2 · Cited by 34
Self-citationSignaling via Amyloid Precursor-Like Proteins APLP1 and APLP2
Orcholski, M. E., Zhang, Q., & Bredesen, D. E. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101470 · Cited by 29
Genome-wide profiling of alternative splicing in Alzheimer's disease
Lai, M. K. P., Esiri, M. M., & Tan, M. G. K. (2014) · Genomics Data · doi:10.1016/j.gdata.2014.09.002 · Cited by 23
Kurronen, A., Pihlaja, R., Pollari, E., Kanninen, K. M., Storvik, M., Wong, G., Koistinaho, M., & Koıstınaho, J. (2012) · World Journal of Neuroscience · doi:10.4236/wjns.2012.22009 · Cited by 8
Cited by
A statistical framework for cross-tissue transcriptome-wide association analysis
Alzheimer’s Disease Genetics Consortium, Hu, Y., Li, M., Lu, Q., Weng, H., Wang, J., Zekavat, S. M., Yu, Z., Li, B., Gu, J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0345-7 · Cited by 411
Associations of Social Isolation and Loneliness With Later Dementia
Shen, C., Rolls, E. T., Cheng, W., Kang, J., Dong, G., Xie, C., Zhao, X.-M., Sahakian, B. J., & Feng, J. (2022) · Neurology · doi:10.1212/wnl.0000000000200583 · Cited by 266
Tanaka, H., Homma, H., Fujita, K., Kondo, K., Yamada, S., Jin, X., Waragai, M., Ohtomo, G., Iwata, A., Tagawa, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14353-6 · Cited by 119
Mammoto, T., Torisawa, Y.-S., Muyleart, M., Hendee, K., Anugwom, C., Gutterman, D., & Mammoto, A. (2019) · Aging · doi:10.18632/aging.102236 · Cited by 43
“Deregulation of YAP1 signaling also contributes to aging-associated diseases such as COPD [32], pulmonary fibrosis [18, 33], and Alzheimer’s disease [34, 35].”
BackgroundUsing blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification
Zhong, H., Zhou, X., Uhm, H., Jiang, Y., Cao, H., Chen, Y., Mak, T. T. W., Lo, R. M. N., Wong, B. W. Y., Cheng, E. Y. L., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13691 · Cited by 25
Metadata
- Authors
- Xu, M., Zhang, D., Luo, R., Wu, Y., Zhou, H., Kong, L., Bi, R., & Yao, Y.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2017-09-16
- Volume
- 14
- Issue
- 2
- Pages
- 215-229
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2754986420
- Cited by
- 296
- References
- 88
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.